ArticleAngiogenesis2018

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab.

Maudy Walraven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.